Introduction
A study of depression in one general practice in Auckland noted that Maori patients were prescribed antidepressants at a much lower rate than non-Maori patients. 1 A similar finding was reported from the 2002 National Primary Medical Care Survey (NatMedCa) on general practice in New Zealand (NZ), which noted that antidepressants were less commonly prescribed for Maori patients. 2 In NatMedCa, antidepressant prescriptions accounted for 1.6% of all Maori prescription items compared to 3.3% of prescription items among non-Maori patients. The prescribing rate was 2.1/100 visits by Maori patients compared to 4.2/100 for non-Maori patients. In total, antidepressants accounted for 12.9% of the nervous system drug prescriptions for Maori compared to 22.0% of non-Maori.
Research on the prevalence of mental health disorders in NZ has indicated that Maori people tend to have similar or somewhat higher prevalence of depression than non-Maori. 3, 4 Given the apparent undertreatment of depression in Maori,
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ORIGInAL sCIEnTIFIC PAPERs what factors might be influential? A 2005 national survey noted that Maori respondents were somewhat less likely to encourage someone with depression to seek professional help than non-Maori (48% vs 58%). 5 In relation to people who do seek primary health care, are general practitioners (GPs) less likely to diagnose depression in Maori? Are they less likely to prescribe antidepressant medication to Maori even when diagnosed, or both? The study reported here addressed the question of why Maori patients seem to be prescribed antidepressants by primary health care providers at a lower rate than non-Maori.
To identify other demographic factors that might be related to the differences in prescribing antidepressant medication to patients, we approached the authors of the NatMedCa study in June 2006 to further analyse their data. 2 In the NatMedCa study data, the diagnosis rate for depression as a percentage of all visits and all ages was 0.7% for Maori men and 2.8% for non-Maori men, and 3.1% for Maori women and 4.5% for non-Maori women. The differences between Maori and non-Maori in both diagnosis and prescribing were most evident among males 25-44 years of age. A key issue is whether these ethnic differences in diagnosing depression and prescribing anti depressants are due to doctor or patient effects, or both.
A qualitative study of mental health consultations in general practice in New Zealand reported four key features that had an impact on consultations with GPs. 6 These included:
practice pressures • (lack of time, a primary focus on physical conditions); sociocultural factors • (stigma attached to patients disclosing mental health problems, patient qualities of stoicism and self-reliance); the medicolegal framework • (e.g. patient access to medical notes, resistance to mental health labels that might disadvantage patients); and the consultation process • (dealing with physical problems first).
GPs employed a number of strategies during consultations and do recognise mental health problems in patients. However practice pressures and the other features noted above result in consultations not being given the label 'mental health'. 6 Previous studies have reported a general trend for depression to be underdiagnosed, or difficult to diagnose in primary health care services [7] [8] [9] and that stigma associated with mental health problems and depression is a major factor in lack of disclosure of relevant information by patients. 10, 11 The aim of the current study was to explore processes related to diagnosis and treatment of depression among Maori and non-Maori patients. The focus was on the views and experiences of GPs in relation to patients who may have depression. The specific research objectives were to: Explore the views of GPs about causes, 1.
diagnosis and treatment of depression among patients.
Develop a framework to describe the processes 2.
and procedures GPs typically use to diagnose and treat depression. Document GPs' views about possible 3.
differences between Maori and non-Maori patients in the diagnosis and treatment of depression.
The study reported here was part of a larger qualitative study examining the treatment of depression by GPs. Given that the New Zealand Health Strategy includes a section on reducing the rate of suicide in New Zealanders 12 a better understanding of depression should help in this endeavour.
WHAT GAP THIs FILLs
What we already know: Maori are prescribed antidepressant medication in primary health care less frequently than non-Maori patients, even though prevalence surveys show high rates of depression among Maori. A likely reason for the difference is that general practitioners are less likely to diagnose Maori patients as having depression.
What this study adds: GPs reported that Maori patients tended to show greater stigma relating to admitting depression and were less likely to talk about being depressed compared to non-Maori patients. Effective communication that allows Maori patients to talk about personal feelings related to depression is more likely when there is an established relationship between the GP and patient.
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Methods
The research design was a qualitative interview study using face-to-face interviews with GPs working in the Auckland region in NZ.
Interview sample
A total of 23 interviews were completed. Both Maori and non-Maori GPs were included to ensure that Maori perspectives were represented in relation to diagnosis and treatment of Maori patients and that the findings were based on a diverse sample. The study began by recruiting Maori practitioners identified through the networks of the research team. For each Maori GP who agreed to participate, a non-Maori GP matched by gender, approximate age and area of practice was recruited for interviewing. The final sample consisted of 11 Maori GPs (seven male, four female) and 12 non-Maori GPs (seven male, five female). All were from practices in the greater Auckland area. Most worked in small group or private practices. Seven worked for iwibased (Maori service provider) health clinics. The interviews were carried out by the second author (BA), a Maori public health researcher (a nonclinician). Ethics approval was obtained from the Northern X Ethics Committee.
Interview questions
The interview schedule included semi-structured and open-ended questions ( Table 1 ). Interviews were conducted in a flexible manner that allowed GPs to share their experiences in relation to the topics covered by the questions.
procedures Face-to-face interviews were conducted with 22 GPs at their health practices. One was interviewed by phone. Most of the interviews took approximately half an hour and all were audiorecorded and transcribed verbatim, with the transcripts used for qualitative analysis.
Data analysis
The analysis used an inductive approach 13 suitable for the research objectives and the interview data collected. An initial analysis was conducted by the interviewer to identify specific themes and categories. Subsequently text from the interview transcripts was imported into the qualitative analysis software NVivo (v7) and analysed by a second team member (DRT). This confirmed the initial categories and constructed an overall framework that incorporated the specific categories and provided an overview of GPs' strategies for identifying and treating depression. The final set of categories was reviewed by the research team. A key focus of the analysis was on GPs' experiences in relation to potential differences in identifying and treating depression between Maori and non-Maori patients, not to systematically compare Maori and non-Maori GPs.
Findings
Findings from the reports of GPs were organised into two sections: (a) the framework incorporating the processes and procedures GPs reported using to diagnose and treat depression and challenges they faced, and (b) differences between Maori and non-Maori patients.
Diagnosing and treating depression
Three primary categories were constructed from the inductive analyses of the interviews. These were: Table 2 shows these categories, the associated subcategories and their descriptions. These provide a framework for understanding the strategies GPs use to identify and treat depression, and a context for the differences some GPs reported between Maori and non-Maori patients.
Identifying depression
Three specific categories relating to identifying depression were evident in GPs' accounts.
Communication effectiveness
Having good communication and a sense of trust between the GP and patient were important in detecting signs of depression. Effective communication requires GPs knowing their patients well enough to be able to recognise any significant changes in their behaviour that might indicate risk factors for depression. Some GPs emphasised that an adequate level of trust by their patients was needed before patients would be comfortable enough to disclose personal issues.
Unless your patient feels that they have confidence in you then they're not going to tell you anything. They're often divulging very personal, private information and they're just not going to tell you unless they have confidence in you.
[Maori GP11, female]
Recognising depression
Most GPs reported that patients with depression could present in several ways, with different symptoms. The most common ways of identifying depression were disclosure of depression directly by the patient, the patient reporting symptoms that were commonly associated with depression and, less commonly, the use of screening questions or a checklist to assess depression. Some GPs noted that women appeared more 
Causes and risks for depression
The most frequently mentioned cause of depression for their patients was related to life events and the patient's social environment. GPs referred to reactive depression developing as a result of a major traumatic life event. Some examples given were breakdown of a relationship, loss of a loved one, or becoming chronically ill.
Many GPs related depression to specific risk factors. A personal or family history of depression was seen as a risk factor, as was having experienced abuse, including physical, sexual, and verbal abuse, as well as drug and alcohol abuse. Isolation was also seen as a major contributing risk factor for depression. Isolation included being separated from families, from social groups, from work, geographical isolation, or emotional isolation. treatment decisions
Treatment options and strategies
The GPs reported two main types of treatment options, pharmaceutical (medication) and nonpharmaceutical treatments such as counselling.
Within each treatment type, treatment decisions were related to patient age, severity of depression, past history, duration of symptoms as well as patient preference.
All GPs spoke about offering medication to treat patients with depression, most commonly for patients who had moderate to severe levels of depression. They reported choosing medication they felt would work best for the level of severity or that would suit the patient. The main non-pharmaceutical treatment GPs mentioned was counselling or psychotherapy. This included psychological and psychiatric therapies such as cognitive behavioural therapy, as well as basic counselling and group counselling.
Some GPs mentioned they preferred to offer their patients counselling therapies first before they would prescribe antidepressant medication, particularly for mild depression. For the more severely depressed cases they were more likely to consider medication.
I don't like using medication for depression unless I'm at a point of saying these other things haven't done enough to help a person. They're still really down to despite our own efforts. So I don't go to medication first. [Maori GP1, male]
Many GPs noted that a combination of both medication and a counselling therapy was their recommended 'best-practice' treatment for moderate to severely depressed patients. Some nonpharmaceutical treatments that were mentioned by the GPs included recommending a 'Green Prescription' for physical exercise to help lift the mood of patients. As well as these treatments, alternative therapies were mentioned by a few GPs. These included rongoa Maori (Maori traditional medicine), homeopathic remedies and acupuncture.
Patient expectations regarding treatment
Several GPs talked about patients' views about, and expectations of, treatment for depression. These often related to patients' attitudes regarding antidepressant medication, which were reported to be diverse. Some mentioned patients who did not want to be given antidepressant medication, because they were seen as being addictive or having negative side effects. In contrast, some patients had no problems with taking antidepressants-they just wanted a 'quick fix'.
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Factors influencing treatment decisions
GPs referred to multiple influences on their choice of treatments for depression. Treatment choices could be influenced by the patient's age, personal preferences and the availability of specific treatments. Discussion with the patients about depression as an illness and the possible treatment options was a priority for many GPs. During discussion with their patients, GPs would talk through the treatment options that they felt were most appropriate for their patient. They were more likely to go ahead with a suggested treatment once the patient had agreed.
I treat them with medication when I feel that they're using all their energy to just control their symptoms and so they've got no extra energy to make changes in their lives. I give the similarity of, it's like a Panadol for a headache. That you take the Panadol to get rid of the headache, but you've still got to work out why you're getting the headaches. And I often say that as an idea to patients.
[Non-Maori GP3, female]
GPs' decisions regarding treatment options for their patients were usually made after assessing the severity and duration of the depression. If the GP thought the patient's level of depression was moderate or severe, they might be more likely to try antidepressants, or antidepressants in conjunction with counselling therapy. Access to counselling services was considered by GPs when considering this option. Some access difficulties mentioned were cost, lack of good quality therapists, or no therapists being available in some regions.
Barriers to effective treatment
Barriers to effective treatment mentioned by GPs included patient concerns about taking medication for depression, views about counselling treatments, and negative stereotyping around mental illness. Many GPs felt that the stigma surrounding antidepressant medication was a significant barrier to patient acceptance and compliance with treatment for depression.
Other barriers to treatment mentioned included beliefs about negative side effects from the drugs, having to take the medication regularly and the lengthy duration of the treatment. Access to counselling treatments was very difficult for many patients due to cost, lengthy waiting lists to therapists, and therapists not being available locally.
treatment outcomes
Three themes were evident in GPs' views about the factors affecting treatment outcomes.
Patient compliance with treatment
Patient compliance or non-compliance with treatment was usually raised in relation to patients not taking their prescribed medication. Some felt lack of compliance in taking antidepressant medication was related to the long course of treatment, or to side effects that some patients reported after taking medication.
Effectiveness of treatments
There was a range of views among GPs about the effectiveness of treatments for depression. Some used observed improvements in their patients as a basis for assessing treatment effectiveness and some referred to research evidence they had read. Most GPs felt that antidepressant medication was in many cases an effective treatment for depression, especially in conjunction with other treatments. While noting benefits from using medication with their patients, some qUALiTATiVE REsEARCH
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GPs also emphasised the limitations and other factors that needed to be considered. Medication could be ineffective or inappropriate for some people. Some medication suited younger patients but were not suitable for elderly people. The uncertain nature of outcomes from taking medication was pointed out.
Patient responses to treatment
The GPs interviewed commented that there was a wide range of patient responses to treatments. One response noted was patients stopping their medication. While patients had various reasons for ceasing their drug treatments, it was common not to notify or discuss the issue with their GP.
… you see them six months later and you ask, how is your depression? And they say, they're a lot better. And you say, did you take the medication? And they say, yeah I took it for a week or I took it for a month, or I didn't take it. So yeah there certainly are some people who don't take it even though they accept it. [Non-Maori GP6, male]
Differences between Maori and non-Maori patients
During the interviews GPs were asked about differences among Maori and non-Maori patients relating to diagnosing and treating depression. The most common theme evident in the analysis related to ethnic differences was the difficulty in identifying or diagnosing depression in Maori due to differences in communication styles.
Identifying depression
Several GPs referred to the difficulties they had with diagnosing depression in some Maori patients. Three specific features evident in the interviews were:
A greater sense of stigma relating to i.
mental illness generally and depression among Maori patients; Maori patients being less likely to talk ii. about being depressed; Effective communication and an i.
established relationship in which the patient trusted the GP being especially important for Maori patients before they are likely to talk about personal feelings such as depression.
The stigma attached to depression was mentioned by several GPs. This was consistent with the themes that Maori patients were less likely to talk about depression and needed to develop a greater sense of trust with GPs before they were willing to talk about personal feelings.
My impression is that the Maori patients are perhaps less likely to be forthcoming… like certain groups, you know they're always thinking about psychological things. 
Factors influencing treatment
Most of the GPs (14 out of 23) stated explicitly that their antidepressant treatment was not related to the patient's ethnicity and that treatment was tailored to the specific needs of patients.
…if I felt medication was indicated on the case I would offer it to anyone, who was even, regardless of their ethnicity, I wouldn't differentiate on that basis. [Non-Maori GP1, male] Whichever treatment option was recommended, consultation with the patient and the patient's agreement were required. The likely cost of treatment and whether the GP thought the patient could afford a specific treatment were issues that were taken into consideration when recommending counselling or similar therapies. 
Discussion
The present study investigated reasons why Maori patients might appear to be less likely to be diagnosed with depression and less likely to be prescribed antidepressant medication. The most likely contributing factor to the disparity was the process of diagnosing depression. If depression was diagnosed, GPs reported that Maori patients were offered or recommended a similar range of treatment options to non-Maori patients. Processes most likely to lead to ethnic differences in diagnosing depression were a greater stigma relating to admitting depression among Maori patients, Maori patients being less likely to talk about being depressed, and the need to have effective communication with their GP. Effective communication that allowed Maori patients to talk about personal feelings, such as qUALiTATiVE REsEARCH those related to depression, was more likely when there was an established relationship between the GP and patient.
The findings of the present study were intended to contribute to an understanding of the reasons why Maori patients are less likely to be prescribed antidepressants even though prevalence studies show Maori to have similar rates of depression to non-Maori. The findings are consistent with previous reports that depression among Maori patients is less likely to be diagnosed by GPs than among non-Maori. The implications of these findings point to the need for GPs to take special care in establishing effective communication with Maori patients, the need to gain the trust of Maori patients and note the reluctance of some Maori patients to talk about personal feelings which may provide clues about mental well-being and depression.
A previous study has suggested that Maori health care providers are better able to establish effective communication with Maori who have experienced cancer. 14 The pattern of findings we have reported is consistent with the view that both patient characteristics and health care provider characteristics are influential in whether Maori patients get effective treatment when they are depressed. 15 Compared to non-Maori, some Maori patients may be reluctant seek professional help for depression and to disclose information that provides GPs with clues about depression. Health care providers who are able to establish effective communication with Maori patients are more likely to diagnose depression among Maori and then be able to treat it.
A limitation of the present study is the relatively small number of GPs interviewed and the reliance on GPs' accounts only. However, the findings do provide a lead for further research on possible reasons for the underdiagnosis of depression among Maori patients. A strength of the study was the inclusion of both Maori and non-Maori GPs. While the GPs interviewed worked in a range of different practices, we did not have sufficient numbers to make comparisons between those working for Maori health care providers and GPs working in other health care settings.
